Physician profile
Frederick A Williams
NPI 1104861137
$2,896.41
in general payments reported to CMS, 2019-2025
15 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $2,099 · 2021: $153 · 2022: $50.37 · 2023: $18.40 · 2024: $87.80 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $2,029.61 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $247.40 | 2019-2025 | |
| Dexcom, INC. | $220.95 | 2019-2022 | |
| Novo Nordisk INC | $122.52 | 2019-2024 | Wegovy |
| Medtronic Minimed, INC. | $61.17 | 2019 | |
| Amgen INC. | $46.30 | 2021 | |
| Xeris Pharmaceuticals, INC. | $39.67 | 2021 | |
| Chiesi USA, INC. | $23.97 | 2025 | Mycapssa |
| Otsuka America Pharmaceutical, INC. | $21.23 | 2022 | |
| Mannkind Corporation | $16.33 | 2020 | |
| Lifescan, INC. | $14.93 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.62 | 2021 | |
| Amarin Pharma, INC. | $13.99 | 2021 | |
| Vistapharm, INC. | $12.49 | 2021 | |
| Alexion Pharmaceuticals, INC. | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.